P1694: COST‐EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VS. TISAGENLECLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: UPDATED SURVIVAL RESULTS FROM THE ZUMA‐1 AND JULIET TRIALS.
| Autor: | Oluwole, Olalekan, Ray, Markqayne, Davies, Neil, Bradford, Rory, Jones, Calum, Patel, Anik, Locke, Frederick |
|---|---|
| Zdroj: | HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text